4//SEC Filing
Alenson Carman 4
Accession 0001439222-21-000021
CIK 0001439222other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:12 PM ET
Size
8.2 KB
Accession
0001439222-21-000021
Insider Transaction Report
Form 4
Alenson Carman
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common stock
2021-02-22+692→ 1,994 total - Tax Payment
Common stock
2021-02-22−199→ 1,795 total - Exercise/Conversion
Restricted stock units
2021-02-22−692→ 691 total→ Common stock (692 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001688865
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:12 PM ET
- Size
- 8.2 KB